Searched for
SUVEN PHARMA SHARE
Ahead of Market: 10 things that will decide stock market action on FridayIndian equities ended higher for a fifth straight session, recovering early losses despite hawkish Federal Reserve comments. Banking stocks...- Quant Small Cap Fund raises stake in Adani Enterprises and 8 others, trims in Aurobindo Pharma and 4 moreQuant Small Cap Fund increased exposure to Adani Enterprises and eight other stocks in May while reducing holdings in Aurobindo Pharma and ...
- Ahead of Market: 10 things that will decide stock market action on TuesdayIndian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators sugge...
- Suven Pharma shares in focus after Q3 profit jumps 78% YoY, revenue up 40%Suven Pharma reported a 78% YoY rise in Q3FY25 net profit to Rs 83.3 crore, with revenue growing 40% to Rs 307.2 crore, driven by its CDMO ...
- Suven Pharma Q3 Results: Net profit surges 78% to Rs 83 crore, revenue up 40%Suven Pharma, backed by Advent, reported a 78% year-on-year rise in net profit to Rs 83.3 crore for Q3FY25 driven by strong demand and busi...
- Suven, Cohance aim to double combined business revenue to Rs 6,000 cr by FY29Suven Pharmaceuticals and Cohance Lifesciences plan to merge and aim to double their revenue to Rs 6,000 crore by FY29 through organic and ...
- National Company Law Tribunal clears Casper Pharma’s merger with Suven PharmaceuticalsThe NCLT Mumbai has approved the merger of Casper Pharma with Suven Pharmaceuticals. This merger aims to improve efficiency, reduce costs, ...
- Merger effect! Suven Pharma shares jump 15% in 2 daysAfter the merger becomes effective, all shareholders of Cohance will be issued shares of Suven at the ratio of 11 shares of Suven for every...
- Suven-Cohance Lifesciences merger announced to create 1st listed PE-led contract manufacturer in Indian pharmaSuven has been 50% owned by Advent since 2022 acquisition, with the remaining with public and institutional shareholders while Cohance is w...
- Suven Pharma, Cohance Lifesciences to merge to bolster CDMO businessPromoter of Suven Pharma, Advent International, had said last year that it would merge the two businesses post the buyout of its significan...
- PE Advent completes acquisition of Suven Pharma, appoints new Board and management teamPrivate equity firm Advent International has completed its majority acquisition of Indian contract development and manufacturing organisati...
- Suven Pharmaceuticals shares jump over 6% after cabinet approves Rs 9,589 crore FDIAccording to the latest shareholding pattern available with the exchanges, as of 30 June 2023, 60% of the company's shareholding is with th...
- Advent International buys Suven Pharma for Rs 6,313 croreAdvent will also launch an open offer for an additional 26% of the company, a listed contract research and manufacturing services (CRAMS) b...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crMarket capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crAnnouncement expected as early as Monday morning. Open offer if fully subscribed to could make it a $1 bn deal
- Accumulate Suven Pharmaceuticals, target price Rs 602: Geojit Financial ServicesSuven Pharma’s total revenues grew 40% YoY to Rs.364 crore with the Formulations and CRAMS (pharma) reporting stellar growth this quarter o...
- Suven Pharma acquires Hyderabad-based formulation maker for Rs 155 croreSuven will purchase100% of share capital from CPPL existing investors. Suven didn't provide details like annual turnover of the acquired as...
- Buy Suven Pharma, target price Rs 690: ICICI DirectThe brokerage says despite a significant run up, there is still scope for upside as the company is still trading at a significant discount ...
- Suven plans to buy US-based Rising Pharmaceuticals' assetsShore Suven Pharma Inc is a joint venture between Suven Life Sciences and Shore Pharma Investments LLC of USA.
- Suven Life Q3 net down 16 pc at Rs 1.29 crSuven Life Sciences today posted a rise of 16.21 per cent in net profit to Rs 1.29 crore for the third quarter ended December 31, 2011.
Load More
